prostate cancer

Medivation Prostate Cancer Drug Launches Hot

Medivation Prostate Cancer Drug Launches Hot

TheStreet.com

Submitted by moderatorj on Mon, 10/15/2012 - 19:12

Physician bias in prostate cancer treatment? | MassDevice.com On Call

Physician bias in prostate cancer treatment? | MassDevice.com On Call

Mass Device

Dendreon and Celgene Cancer Treatment Catalysts Face Rocky Road

Dendreon and Celgene Cancer Treatment Catalysts Face Rocky Road

Wall St. Cheat Sheet

Opko's 4KScore Could Generate Over $1.8 Billion Annually

Opko's 4KScore Could Generate Over $1.8 Billion Annually

Seeking Alpha

Medivation and Astellas Announce New Data From XTANDI(R) (enzalutamide) Pivotal Study

Medivation and Astellas Announce New Data From XTANDI(R) (enzalutamide) Pivotal Study

Yahoo/MarketWire

Progenics Pharmaceuticals Initiates Phase 2 Clinical Trial of PSMA ADC in Prostate Cancer Patients

Progenics Pharmaceuticals Initiates Phase 2 Clinical Trial of PSMA ADC in Prostate Cancer Patients

Pipeline Review

Five-Cent Diabetes Pill From 1958 May Be New Cancer Drug

Five-Cent Diabetes Pill From 1958 May Be New Cancer Drug

Bloomberg

Medivation Gets Surprise Early Approval For Prostate Cancer Pill

Medivation Gets Surprise Early Approval For Prostate Cancer Pill

Seeking Alpha

J&J's Zytiga to be reviewed faster by FDA for additional use

J&J's Zytiga to be reviewed faster by FDA for additional use

Reuters

Upcoming Catalysts For Exelixis And Immunogen

Upcoming Catalysts For Exelixis And Immunogen

Seeking Alpha